Specialty Pharma Journal

FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX:…
Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq: INCY) today announced that data from th…
Natera Announces SMART Study Data for Aneuploidy and 22q Unblinded

SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and le…
Aimmune Agrees to be Acquired by Nestlé Health Science for $2 Billion

BRISBANE, Calif.–(BUSINESS WIRE)–Aug. 31, 2020– Aimmune Therapeutics Inc. (Nasdaq:…
Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST) …

The 2017 Hepatitis C Treatment Landscape

February 22, 2017 Blog

Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
Understanding the Hepatitis C Testing Process

February 15, 2017 Blog
Potential New Medication for Lymphoma

February 8, 2017 Blog

FDA Rejects Biomarin’s Application for its Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

August 20, 2020 FDA News, Hemophilia

SAN RAFAEL, Calif., Aug. 19, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the …

Johnson & Johnson to Acquire Autoimmune Disease Specialist Momenta for $6.5 Billion

August 20, 2020 Business News

NEW BRUNSWICK, N.J., August 19, 2020 – Johnson & Johnson (NYSE:JNJ) today announced it has entered …

Kedrion and Kamada Announce Post-Marketing Pediatric Trial of a Human Rabies Immune Globulin Met its Primary Objective

August 20, 2020 Immune Deficiencies, Specialty Pharmacy

REHOVOT, Israel and FORT LEE, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ …

Merck’s Keytruda with Chemotherapy Significantly Improved OS and PFS Compared with Chemotherapy in Locally Advanced or First-Line Metastatic Esophageal Cancer

August 20, 2020 Oncology

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

Precision BioSciences Receives Fast Track Disease Designation from FDA for PBCAR0191 Investigational Allogeneic CAR T Cell Therapy

August 20, 2020 FDA News, Oncology

DURHAM, N.C., Aug. 19, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical …

FDA Rejects Gilead’s Filgotinib for Treatment of Rheumatoid Arthritis Over Safety Concerns

August 20, 2020 FDA News, Rheumatoid Arthritis

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and …

Roche and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19

August 20, 2020 Business News, Infectious Diseases

Basel, 19 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and Regeneron (NASDAQ: REGN) …

Lilly and Innovent Announce Global Expansion of TYVYT Licensing Agreement

August 20, 2020 Business News, Oncology

INDIANAPOLIS and SUZHOU, China, Aug. 18, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Innovent Biologics, Inc. (HKEX: 01801) …

Immunicum Announces Update on Survival Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer

August 20, 2020 Oncology

Immunicum AB (publ) announced today an update on survival data from the randomized Phase II MERECA …

Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration

August 20, 2020 Business News, Oncology

FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics today …

Additional Data from Clovis Oncology’s Clinical Trial Evaluating Rubraca for the Treatment of mCRPC in Patients with BRCA1/2 Gene Mutations Published

August 20, 2020 Oncology

BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that data from the Phase 2 …

Mustang Bio’s MB-107 Granted Rare Pediatric Disease Designation from the FDA for Treatment of X-linked Severe Combined Immunodeficiency

August 17, 2020 FDA News, Immune Deficiencies, Rare Diseases

WORCESTER, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a …

Bristol Myers Squibb Announces Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program

August 17, 2020 Business News, Oncology

NEW YORK & WALTHAM, Mass.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) and Dragonfly Therapeutics, Inc. (“Dragonfly”), today …

Thermo Fisher Scientific Signs Oncology Companion Diagnostic Agreement with Hengrui Therapeutics

August 17, 2020 Business News, Oncology, Technology & Devices

CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic …

OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices

August 17, 2020 Business News, Oncology, Precision Medicine

CAMBRIDGE, Mass. & NASHVILLE, Tenn.–(BUSINESS WIRE)–Foundation Medicine, Inc. and OneOncology today announced a new joint initiative …

Page 5 of 325« First...3 456 7 »10 20 30...Last »

Recent Posts